Veraxa Biotech AG Ordinary Shares (VRXA)
Stock · NASDAQ · Health Care
$1.35as of 8/28/2026
Price chart
Open in TradingViewActive signals
Resistance level
$1.91
Industry
Biotechnology: Pharmaceutical Preparations
About VRXA
VERAXA Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, with some in clinical deve…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Fundamentals
- 1-day range
- $1.33$1.43
- Market cap
- $258.78M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- 0.14
- Avg. volume
- 479.9K
52-week range
$1.32$27.36
Veraxa Biotech AG Ordinary Shares Competitors
Chosen by industry and closest market cap.
- VRXAVeraxa Biotech AG Ordinary Shares$1.36▼ 5.56%Market cap $258.78MP/E —$1.32$27.36
- ALXOALX Oncology Holdings Inc. Common Stock$2▼ 2.44%Market cap $259.71MP/E —$0.96$2.66
- ELDNEledon Pharmaceuticals Inc. Common Stock$3.19▼ 3.92%Market cap $264.75MP/E —$1.35$4.6
- IMRXImmuneering Corporation Class A Common Stock$4.99▼ 4.22%Market cap $269.79MP/E —$3.86$10.08
- BCYCBicycle Therapeutics plc American Depositary Shares$4.21▼ 2.77%Market cap $270.87MP/E —$3.75$9.16
- MGNXMacroGenics Inc. Common Stock$4.13▲ 1.23%Market cap $242.81MP/E —$1.29$5.08
- ADAGAdagene Inc. American Depositary Shares$3.68▼ 5.64%Market cap $239.77MP/E —$1.3$4.85
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| VRXA Veraxa Biotech AG Ordinary Shares | $258.78M | — | $1.36 | ▼ 5.56% | $1.32$27.36 |
| ALXO ALX Oncology Holdings Inc. Common Stock | $259.71M | — | $2 | ▼ 2.44% | $0.96$2.66 |
| ELDN Eledon Pharmaceuticals Inc. Common Stock | $264.75M | — | $3.19 | ▼ 3.92% | $1.35$4.6 |
| IMRX Immuneering Corporation Class A Common Stock | $269.79M | — | $4.99 | ▼ 4.22% | $3.86$10.08 |
| BCYC Bicycle Therapeutics plc American Depositary Shares | $270.87M | — | $4.21 | ▼ 2.77% | $3.75$9.16 |
| MGNX MacroGenics Inc. Common Stock | $242.81M | — | $4.13 | ▲ 1.23% | $1.29$5.08 |
| ADAG Adagene Inc. American Depositary Shares | $239.77M | — | $3.68 | ▼ 5.64% | $1.3$4.85 |
P/E shows — for peers not currently carrying a live signal of their own.
See the full, filterable feed with live charts on the MarketWall dashboard.